ARG1 and neoplasm: They facilitate tumor immune escape, angiogenesis, metastasis, and treatment resistance through multiple mechanisms: (1) Suppression of anti-tumor immune responses: MDSCs deplete arginine in the microenvironment via Arg1 and iNOS, thereby inhibiting the expression of the T cell CD3ζ chain and suppressing T cell activation and proliferation.